Document is current
Any future updates will be listed below
-
Authors
Hussmann, Bjoern
Hilbert-Carius, Peter https://orcid.org/0000-0002-4704-2377
Berk, Till https://orcid.org/0000-0001-9582-1810
Struck, Manuel Florian https://orcid.org/0000-0002-0070-3406
Strasser, Erwin
Oezkurtul, Orkun https://orcid.org/0000-0003-1956-4896
Hossfeld, Bjoern
Goossen, Käthe https://orcid.org/0000-0002-1436-1144
Kugler, Charlotte M. https://orcid.org/0000-0003-4170-3290
Maegele, Marc
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 19 September 2025
First Online: 14 November 2025
Declarations
:
: Bjoern Hussmann, Peter Hilbert‐Carius, Till Berk, Manuel Florian Struck, Erwin Strasser, Orkun Oezkurtul, Bjoern Hossfeld, Kaethe Goossen, Charlotte M. Kugler declare no competing interests. Marc Maegele declares that he has received honoraria for lectures, participation in expert/advisory board committees and financial support for participation in congresses and scientific projects from Abbott, Astra Zeneca, Baxter, Bayer, Biotest, CSL Behring, IL-Werfen/TEM-International, LFB, Biomedicaments France, Portola and Octapharma.
: Ethical approval was not required because the study used publicly accessible documents as evidence.
